Search research articles
Contact Us
Filters
Showing results (81-90 of 175) with videos related to
Page
of 18
Sort By:
Diabetes Care
|
August 1, 1994
Remission of proteinuria following correction of hyperlipidemia in NIDDM patients with nondiabetic glomerulopathy
D Dubois, P Chanson, J Timsit, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1997
Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans
J Young, B Couzinet, K Nahoul, et al.
Journal of Neurology
|
March 21, 1998
Uncommon early-onset neuropathy in diabetic patients
G Said, A Bigo, A Améri, et al.
Neuropeptides
|
March 1, 1994
Calcitonin genes (I and II) expression in human nervous and medullary thyroid carcinoma tissues
R Cohen, S Giscard-Darteville, S Bracq, et al.
The New England Journal of Medicine
|
July 2, 1987
Visual improvement with SMS 201-995 in a patient with a thyrotropin-secreting pituitary adenoma
P J Guillausseau, P Chanson, J Timsit, et al.
Hormone Research
|
January 1, 1989
Experience of a six-month treatment with sandostatin at increasing doses in acromegaly
G Sassolas, P Fossati, P Chanson, et al.
The Journal of Endocrinology
|
November 1, 1996
Characterization of a monoclonal antibody reacting with the free human luteinizing hormone beta-subunit
J Pantel, P Robert, F Troalen, et al.
Acta Endocrinologica
|
April 1, 1991
Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995)
A Warnet, E Lajeunie, F Gelbert, et al.
Clinical Endocrinology
|
March 1, 1993
Inhibin and follicle-stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumour volume in men
N Lahlou, E Le Nestour, P Chanson, et al.
Presse Medicale (Paris, France : 1983)
|
October 7, 1989
[Neurologic manifestations of atrophic polychondritis]
J M Netter, P J Guillausseau, D Fafet, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 175) with videos related to
Sort By:
Page
of 18
Diabetes Care
|
August 1, 1994
Remission of proteinuria following correction of hyperlipidemia in NIDDM patients with nondiabetic glomerulopathy
D Dubois, P Chanson, J Timsit, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1997
Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans
J Young, B Couzinet, K Nahoul, et al.
Journal of Neurology
|
March 21, 1998
Uncommon early-onset neuropathy in diabetic patients
G Said, A Bigo, A Améri, et al.
Neuropeptides
|
March 1, 1994
Calcitonin genes (I and II) expression in human nervous and medullary thyroid carcinoma tissues
R Cohen, S Giscard-Darteville, S Bracq, et al.
The New England Journal of Medicine
|
July 2, 1987
Visual improvement with SMS 201-995 in a patient with a thyrotropin-secreting pituitary adenoma
P J Guillausseau, P Chanson, J Timsit, et al.
Hormone Research
|
January 1, 1989
Experience of a six-month treatment with sandostatin at increasing doses in acromegaly
G Sassolas, P Fossati, P Chanson, et al.
The Journal of Endocrinology
|
November 1, 1996
Characterization of a monoclonal antibody reacting with the free human luteinizing hormone beta-subunit
J Pantel, P Robert, F Troalen, et al.
Acta Endocrinologica
|
April 1, 1991
Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995)
A Warnet, E Lajeunie, F Gelbert, et al.
Clinical Endocrinology
|
March 1, 1993
Inhibin and follicle-stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumour volume in men
N Lahlou, E Le Nestour, P Chanson, et al.
Presse Medicale (Paris, France : 1983)
|
October 7, 1989
[Neurologic manifestations of atrophic polychondritis]
J M Netter, P J Guillausseau, D Fafet, et al.
Page
of 18